Overcoming Barriers to Adopting and Implementing Pharmacotherapy: the Medication Research Partnership

Raina Croff, Kim Hoffman, Kelly Alanis-Hirsch, Jay Ford, Dennis McCarty, Laura Schmidt

Research output: Contribution to journalArticle

Abstract

Pharmacotherapy includes a growing number of clinically effective medications for substance use disorder, yet there are significant barriers to its adoption and implementation in routine clinical practice. The Medication Research Partnership (MRP) was a successful effort to promote adoption of pharmacotherapy for opioid and alcohol use disorders in nine substance abuse treatment centers and a commercial health plan. This qualitative analysis of interviews (n = 39) conducted with change leaders at baseline and at the end/beginning of 6-month change cycles explains how treatment centers overcame obstacles to the adoption, implementation, and sustainability of pharmacotherapy. Results show that barriers to adopting, implementing, and sustaining pharmacotherapy can be overcome through incremental testing of organizational change strategies, accompanied by expert coaching and a learning community of like-minded professionals. The greatest challenges lie in overcoming abstinence-only philosophies, establishing a business case for pharmacotherapy, and working with payers and pharmaceutical representatives.

Original languageEnglish (US)
Pages (from-to)1-10
Number of pages10
JournalJournal of Behavioral Health Services and Research
DOIs
StateAccepted/In press - May 29 2018

Fingerprint

medication
Drug Therapy
coaching
organizational change
Research
pharmaceutical
substance abuse
alcohol
sustainability
expert
leader
Substance Abuse Treatment Centers
Organizational Innovation
interview
health
learning
community
Opioid Analgesics
Substance-Related Disorders
Alcohols

ASJC Scopus subject areas

  • Health(social science)
  • Health Policy
  • Public Health, Environmental and Occupational Health

Cite this

Overcoming Barriers to Adopting and Implementing Pharmacotherapy : the Medication Research Partnership. / Croff, Raina; Hoffman, Kim; Alanis-Hirsch, Kelly; Ford, Jay; McCarty, Dennis; Schmidt, Laura.

In: Journal of Behavioral Health Services and Research, 29.05.2018, p. 1-10.

Research output: Contribution to journalArticle

@article{d1865511c98e4091a6f624033d0f0117,
title = "Overcoming Barriers to Adopting and Implementing Pharmacotherapy: the Medication Research Partnership",
abstract = "Pharmacotherapy includes a growing number of clinically effective medications for substance use disorder, yet there are significant barriers to its adoption and implementation in routine clinical practice. The Medication Research Partnership (MRP) was a successful effort to promote adoption of pharmacotherapy for opioid and alcohol use disorders in nine substance abuse treatment centers and a commercial health plan. This qualitative analysis of interviews (n = 39) conducted with change leaders at baseline and at the end/beginning of 6-month change cycles explains how treatment centers overcame obstacles to the adoption, implementation, and sustainability of pharmacotherapy. Results show that barriers to adopting, implementing, and sustaining pharmacotherapy can be overcome through incremental testing of organizational change strategies, accompanied by expert coaching and a learning community of like-minded professionals. The greatest challenges lie in overcoming abstinence-only philosophies, establishing a business case for pharmacotherapy, and working with payers and pharmaceutical representatives.",
author = "Raina Croff and Kim Hoffman and Kelly Alanis-Hirsch and Jay Ford and Dennis McCarty and Laura Schmidt",
year = "2018",
month = "5",
day = "29",
doi = "10.1007/s11414-018-9616-9",
language = "English (US)",
pages = "1--10",
journal = "Journal of Behavioral Health Services and Research",
issn = "1094-3412",
publisher = "Springer New York",

}

TY - JOUR

T1 - Overcoming Barriers to Adopting and Implementing Pharmacotherapy

T2 - the Medication Research Partnership

AU - Croff, Raina

AU - Hoffman, Kim

AU - Alanis-Hirsch, Kelly

AU - Ford, Jay

AU - McCarty, Dennis

AU - Schmidt, Laura

PY - 2018/5/29

Y1 - 2018/5/29

N2 - Pharmacotherapy includes a growing number of clinically effective medications for substance use disorder, yet there are significant barriers to its adoption and implementation in routine clinical practice. The Medication Research Partnership (MRP) was a successful effort to promote adoption of pharmacotherapy for opioid and alcohol use disorders in nine substance abuse treatment centers and a commercial health plan. This qualitative analysis of interviews (n = 39) conducted with change leaders at baseline and at the end/beginning of 6-month change cycles explains how treatment centers overcame obstacles to the adoption, implementation, and sustainability of pharmacotherapy. Results show that barriers to adopting, implementing, and sustaining pharmacotherapy can be overcome through incremental testing of organizational change strategies, accompanied by expert coaching and a learning community of like-minded professionals. The greatest challenges lie in overcoming abstinence-only philosophies, establishing a business case for pharmacotherapy, and working with payers and pharmaceutical representatives.

AB - Pharmacotherapy includes a growing number of clinically effective medications for substance use disorder, yet there are significant barriers to its adoption and implementation in routine clinical practice. The Medication Research Partnership (MRP) was a successful effort to promote adoption of pharmacotherapy for opioid and alcohol use disorders in nine substance abuse treatment centers and a commercial health plan. This qualitative analysis of interviews (n = 39) conducted with change leaders at baseline and at the end/beginning of 6-month change cycles explains how treatment centers overcame obstacles to the adoption, implementation, and sustainability of pharmacotherapy. Results show that barriers to adopting, implementing, and sustaining pharmacotherapy can be overcome through incremental testing of organizational change strategies, accompanied by expert coaching and a learning community of like-minded professionals. The greatest challenges lie in overcoming abstinence-only philosophies, establishing a business case for pharmacotherapy, and working with payers and pharmaceutical representatives.

UR - http://www.scopus.com/inward/record.url?scp=85047662261&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047662261&partnerID=8YFLogxK

U2 - 10.1007/s11414-018-9616-9

DO - 10.1007/s11414-018-9616-9

M3 - Article

C2 - 29845513

AN - SCOPUS:85047662261

SP - 1

EP - 10

JO - Journal of Behavioral Health Services and Research

JF - Journal of Behavioral Health Services and Research

SN - 1094-3412

ER -